Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome.
暂无分享,去创建一个
P. López-Jaramillo | A. Zanchetti | F. Lanas | S. Harrap | M. Foss | H. Schmid | E. Peñaherrera | G. Márquez | J. Z. Parra-Carrillo | A. Ramirez | Alfonso Bryce | L. Cobos | Fernando Lizcano | R. Botero | J. Z. Parra Carrillo | I. Sinay | M. Bendersky | R. Sanchez | J. Lara | M. Díaz | Iván D. Sierra | M. Urina | F. Lizcano | Joffre Lara
[1] Giuseppe Ambrosio,et al. Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications , 2012, Hypertension.
[2] Morris J. Brown,et al. A Double-Blind, Placebo-Controlled, Crossover Trial Comparing the Effects of Amiloride and Hydrochlorothiazide on Glucose Tolerance in Patients With Essential Hypertension , 2012, Hypertension.
[3] R. Wong,et al. Coexistence of Obesity and Anemia in Older Mexican Adults , 2012, Ageing international.
[4] M. Rutter,et al. Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care. , 2011, European heart journal.
[5] G. Mancia,et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.
[6] S. Bangalore,et al. Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials , 2011, Circulation.
[7] F. Márquez-Sandoval,et al. The prevalence of metabolic syndrome in Latin America: a systematic review , 2011, Public Health Nutrition.
[8] P. López-Jaramillo,et al. Epidemic of cardiometabolic diseases: a Latin American point of view , 2011, Therapeutic advances in cardiovascular disease.
[9] S. Nesbitt,et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. , 2010, Hypertension.
[10] G. Bakris,et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.
[11] J. Lewis. Blood pressure control in chronic kidney disease: is less really more? , 2010, Journal of the American Society of Nephrology : JASN.
[12] M. Velasco,et al. The Maracaibo city metabolic syndrome prevalence study: design and scope. , 2010, American journal of therapeutics.
[13] C. Seas,et al. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[14] A. AlShehri. Metabolic syndrome and cardiovascular risk. , 2010, Journal of family & community medicine.
[15] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[16] A. Dominiczak,et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. , 2009, Journal of hypertension.
[17] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[18] C. Boissonnet,et al. Open Access Cardiovascular Diabetology Prevalence of the Metabolic Syndrome in Latin America and Its Association with Sub-clinical Carotid Atherosclerosis: the Carmela Cross Sectional Study , 2022 .
[19] Salim Yusuf,et al. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.
[20] P. López-Jaramillo. Cardiometabolic disease in latin america: the role of fetal programming in response to maternal malnutrition. , 2009, Revista espanola de cardiologia.
[21] G. Mancia,et al. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.
[22] M. Franco,et al. Stunting growth: association of the blood pressure levels and ACE activity in early childhood , 2009, Pediatric Nephrology.
[23] K. Arheart,et al. Prevalence of Metabolic Syndrome in US-Born Latin and Caribbean Youth , 2009, Journal of Immigrant and Minority Health.
[24] Giuseppe Mancia,et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document , 2009, Blood pressure.
[25] G. Bakris,et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.
[26] F. A. Moura,et al. Short stature of mothers from an area endemic for undernutrition is associated with obesity, hypertension and stunted children: a population-based study in the semi-arid region of Alagoas, Northeast Brazil , 2008, British Journal of Nutrition.
[27] P. López-Jaramillo. Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. , 2008, Journal of hypertension.
[28] S. Rodríguez,et al. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity , 2008, BMC pediatrics.
[29] P. López-Jaramillo,et al. Are Nutrition-Induced Epigenetic Changes the Link Between Socioeconomic Pathology and Cardiovascular Diseases? , 2008, American journal of therapeutics.
[30] Yolanda Torres,et al. Prevalencia y comportamiento de los factores de riesgo del síndrome metabólico según los diferentes intervalos de edad, en una población femenina del área de influencia de la Clínica Las Américas, en Medellín - Colombia , 2008 .
[31] F. Manzur,et al. Phenotypic and metabolic characterization of the metabolic syndrome in Cartagena de Indias , 2008 .
[32] P. López-Jaramillo,et al. Inter-relationships between body mass index, C-reactive protein and blood pressure in a Hispanic pediatric population. , 2008, American journal of hypertension.
[33] Li-sheng Liu,et al. Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.
[34] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[35] Sabrina E. Noel,et al. Metabolic Syndrome in Elderly Living in Marginal Peri‐Urban Communities in Quito, Ecuador , 2008, Public Health Nutrition.
[36] D. Casarini,et al. Circulating renin-angiotensin system and catecholamines in childhood: is there a role for birthweight? , 2008, Clinical science.
[37] Executive Summary: Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.
[38] A. Barcelo,et al. Waist circumference, BMI and the prevalence of self-reported diabetes among the elderly of the United States and six cities of Latin America and the Caribbean. , 2007, Diabetes research and clinical practice.
[39] Renke Maas,et al. Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome. , 2007, International journal of cardiology.
[40] H. Bettiol,et al. Metabolic syndrome in young adults from two socioeconomic Latin American settings. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[41] Eduardo Fasce,et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile , 2007, Journal of hypertension.
[42] A. Dominiczak,et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.
[43] X. Rabasseda. New joint European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. , 2007, Timely topics in medicine. Cardiovascular diseases.
[44] P. Montoya. SÍNDROME METABÓLICO EN UNA POBLACIÓN RURAL Y UNA POBLACIÓN URBANA DE LA REGIÓN ANDINA COLOMBIANA , 2007 .
[45] J. Medina-Lezama,et al. Prevalence and patterns of hypertension in Peruvian Andean Hispanics: the PREVENCION study. , 2007, Journal of the American Society of Hypertension : JASH.
[46] P. López-Jaramillo,et al. The utility of different definitions of metabolic syndrome in Andean population. , 2007, International journal of cardiology.
[47] E. Kabagambe,et al. Nonfatal Acute Myocardial Infarction in Costa Rica: Modifiable Risk Factors, Population-Attributable Risks, and Adherence to Dietary Guidelines , 2007, Circulation.
[48] J. Blümel,et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women , 2007, Climacteric : the journal of the International Menopause Society.
[49] P. López-Jaramillo,et al. A proposal for an appropriate central obesity diagnosis in Latin American population. , 2006, International journal of cardiology.
[50] C. Agusti. Epidemiología de la Hipertensión Arterial en el Perú , 2006 .
[51] V. Merchán. Síndrome metabólico y riesgo de enfermedad cardiovascular , 2005 .
[52] Barry R Davis,et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. , 2005, JAMA.
[53] Neil Chapman,et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.
[54] E. C. Moura,et al. Socioeconomic status and obesity in adult populations of developing countries: a review. , 2004, Bulletin of the World Health Organization.
[55] B. Popkin,et al. Obesity and inequities in health in the developing world , 2004, International Journal of Obesity.
[56] M. Stern,et al. Secular trends in obesity in Mexico City and in San Antonio. , 2004, Nutrition reviews.
[57] A. Dyer,et al. Ethnic Differences in correlates of obesity between Latin-American and black Women. , 2004, Obesity research.
[58] A. Sawaya,et al. Short stature, obesity and arterial hypertension in a very low income population in North-eastern Brazil. , 2004, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[59] D. Schriger,et al. Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? , 2004, Diabetes care.
[60] P. López-Jaramillo,et al. Using waist circumference as a screening tool to identify colombian subjects at cardiovascular risk , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[61] Á. Avezum,et al. Risk factors for myocardial infarction in Brazil. , 2003, American heart journal.
[62] C. Bouchard,et al. Effect of malnutrition during the first year of life on adult plasma insulin and glucose tolerance. , 2003, Metabolism: clinical and experimental.
[63] D. Bell. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. , 2003, Diabetes care.
[64] G. Reaven,et al. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.
[65] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[66] Yutaka Imai,et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.
[67] G. Tognoni,et al. Treatment and control of arterial hypertension in a rural community in Ecuador , 2003, The Lancet.
[68] R. Sesso,et al. Increased blood pressure in adolescents of low socioeconomic status with short stature , 2003, Pediatric Nephrology.
[69] Kazuomi Kario,et al. Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.
[70] A. Tuttolomondo,et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. , 2003, Stroke.
[71] Majid Ezzati,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[72] G. Grunwald,et al. Differences in resting metabolic rate between white and African-American young adults. , 2002, Obesity research.
[73] R. Bonow,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications , 2002, Circulation.
[74] S. Grundy,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association , 2002, Circulation.
[75] G. Velásquez-Melendez,et al. Evaluation of waist circumference to predict general obesity and arterial hypertension in women in Greater Metropolitan Belo Horizonte, Brazil. , 2002, Cadernos de saude publica.
[76] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[77] S. Barreto,et al. Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil--The Bambuí Health and Ageing Study. , 2001, Arquivos brasileiros de cardiologia.
[78] A Berber,et al. Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population , 2001, International Journal of Obesity.
[79] J E Schwartz,et al. Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives , 2001, Hypertension.
[80] Claudio D. González,et al. Obesity prevalence and trends in Latin‐American countries , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[81] J. Staessen,et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. , 2001, Archives of internal medicine.
[82] M. Onis,et al. Prevalence and trends of overweight among preschool children in developing countries. , 2000, The American journal of clinical nutrition.
[83] M. Rodríguez-Moran,et al. Prevalence of hypertension in indigenous inhabitants of traditional communities from the north of Mexico , 2000, Journal of Human Hypertension.
[84] R. Schrier,et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.
[85] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[86] M. Cabana,et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.
[87] C. Rotimi,et al. Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[88] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[89] KlasMalmberg,et al. Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction , 1999 .
[90] K. Walker,et al. Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. , 1999, Diabetes care.
[91] C. Bulpitt,et al. Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .
[92] R J Shephard,et al. Exercise as cardiovascular therapy. , 1999, Circulation.
[93] J A Staessen,et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.
[94] C. Szwarcwald,et al. Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors – the Rio de Janeiro Study , 1998, Journal of hypertension.
[95] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[96] L. Grummer-Strawn,et al. Obesity in Latin American women and children. , 1998, The Journal of nutrition.
[97] M. Rodríguez-Morán,et al. Prevalencia de hipertensión arterial y factores asociados en la población rural marginada , 1998 .
[98] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[99] L. Barriocanal,et al. Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[100] F. Nieto,et al. Hypertension in Cuba: evidence of a narrow black–white difference , 1998, Journal of Human Hypertension.
[101] Jenny Field,et al. General practitioners' perceptions of the route to evidence based medicine: a questionnaire survey , 1998, BMJ.
[102] L Guize,et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.
[103] J. Colwell. Aspirin Therapy in Diabetes , 1997, Diabetes Care.
[104] Hugh Tunstall-Pedoe,et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.
[105] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[106] W A Ray,et al. Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema , 1996, Clinical pharmacology and therapeutics.
[107] L. Bang,et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. , 1995, American journal of hypertension.
[108] F. Port,et al. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[109] T Delamothe,et al. Wanted: guidelines that doctors will follow. , 1993, BMJ.
[110] S. Woolf. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. , 1992, Archives of internal medicine.
[111] W. McClellan,et al. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[112] L. Tobian,et al. Hypertension and obesity. , 1978, The New England journal of medicine.
[113] N. Serrano,et al. [Impact of the new definitions in the prevalence of the metabolic syndrome in an adult population at Bucaramanga, Colombia]. , 2007, Biomedica : revista del Instituto Nacional de Salud.
[114] W. Elliott. Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus: Results of Prospectively Designed Overviews of Randomized Trials , 2006 .
[115] A. Tuttolomondo,et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. , 2005, Neurology.
[116] Irene M Stratton,et al. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. , 2004, Diabetes care.
[117] B. Jönsson. Revealing the cost of Type II diabetes in Europe. , 2002, Diabetologia.
[118] G. Bakris,et al. SPECIAL REPORT Preserving Renal Function in Adults With Hypertension and Diabetes: A Consensus Approach , 2000 .
[119] C. Bulpitt,et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. , 1999, The New England journal of medicine.
[120] E. O’Brien,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.
[121] American College of Sports Medicine and American Diabetes Association joint position statement. Diabetes mellitus and exercise. , 1997, Medicine and science in sports and exercise.
[122] R. DeFronzo. Diabetic nephropathy: Etiologic and therapeutic considerations , 1995 .
[123] P. Savage,et al. Correlates of obesity in young black and white women: the CARDIA Study. , 1992, American journal of public health.
[125] G. Duvel. The study group. , 1980 .